Movicol Neutral

Macrogol 3350, the active ingredient in Movicol Neutral, is an osmotic laxative presented as an oral solution for oral use. It treats constipation and faecal impaction in adults and children. GNH USA supplies Movicol Neutral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Neutral is an osmotic laxative used to manage conditions affecting bowel transit. - Constipation: softens stool and promotes regular bowel movements. - Faecal impaction: helps break down hardened stool to facilitate evacuation. - Chronic constipation: provides long‑term relief by maintaining stool hydration.

Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas leading to discomfort. - Nausea: feeling of unease or urge to vomit. - Diarrhoea: loose, watery stools occurring more frequently.

Serious or Rare Side Effects: - Severe dehydration: excessive loss of body fluids requiring medical attention. - Electrolyte imbalance: abnormal levels of sodium, potassium, or chloride. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: intense pain that may indicate complications.

Before using Movicol Neutral, consider the following precautions. - Renal function assessment: evaluate kidney health to avoid fluid overload. - Electrolyte monitoring: check serum electrolytes, especially in long‑term use. - Elderly patients: use cautiously as they may be more susceptible to dehydration. - Intestinal obstruction: avoid use if a blockage is present. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Movicol Neutral may interact with other medicines. Major Interactions (Avoid): - High‑dose potassium supplements: risk of hyperkalaemia. - Loop diuretics: may exacerbate electrolyte disturbances. - Lithium therapy: can alter lithium plasma concentrations. Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce laxative efficacy. - Opioid analgesics: increased risk of constipation. - NSAIDs: potential for additive gastrointestinal irritation.